<DOC>
	<DOCNO>NCT00006326</DOCNO>
	<brief_summary>The purpose study see 3 anti-HIV drug combination safe effective patient fail previous anti-HIV treatment use nelfinavir ( NFV ) .</brief_summary>
	<brief_title>Safety Effectiveness 3 Anti-HIV Treatments Patients Who Have Failed Previous Treatments Containing Nelfinavir</brief_title>
	<detailed_description>Patients receive 1 3 salvage regimen . Treatments A B include delavirdine , 1 2 dos indinavir , 2 nucleoside reverse transcriptase inhibitor ( NRTIs ) patient expose . Treatment C include ritonavir , indinavir , 2 NRTIs patient expose . When virologic failure first observe , patient must return 2 week confirmation failure start salvage regimen within 1 month first assay failure observe . Patients less 400 copies/ml HIV RNA 16 week therapy consider responder continue study . Those 400 copies/ml 16 week therapy consider nonresponders discontinue study . In addition , patient respond subsequently rebound viral load 0.5 log nadir great 400 copies/ml 2 consecutive assay least 2 week apart consider treatment failure discontinue study . Patients regular physical exam , well virologic , immunologic , pharmacokinetic assessment .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Nelfinavir</mesh_term>
	<mesh_term>Indinavir</mesh_term>
	<mesh_term>Delavirdine</mesh_term>
	<criteria>Inclusion Criteria Patients may eligible study : Are HIVpositive . Had viral load le 400 copies/ml , follow increase viral load take antiHIV drug combination include NFV ( treatment failure ) . Can start study treatment within 1 month treatment failure . Have viral load le 30,000 copies/ml enter study . Have take nonnucleoside reverse transcriptase inhibitor ( NNRTIs ) protease inhibitor ( PIs ) NFV .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2002</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>HIV Protease Inhibitors</keyword>
	<keyword>Ritonavir</keyword>
	<keyword>Indinavir</keyword>
	<keyword>Delavirdine</keyword>
	<keyword>Reverse Transcriptase Inhibitors</keyword>
	<keyword>Salvage Therapy</keyword>
	<keyword>Anti-HIV Agents</keyword>
	<keyword>Viral Load</keyword>
	<keyword>Nelfinavir</keyword>
</DOC>